نتایج جستجو برای: blasts

تعداد نتایج: 4021  

Journal: :Blood 1999
X F Hu A Slater P Kantharidis D Rischin S Juneja R Rossi G Lee J D Parkin J R Zalcberg

The expression of P-glycoprotein (Pgp) is often increased in acute myeloid leukemia (AML). However, little is known of the regulation of Pgp expression by cytotoxics in AML. We examined whether Pgp expression and function in leukemic blasts was altered after a short exposure to cytotoxics. Blasts were isolated from 19 patients with AML (15 patients) or chronic myeloid leukemia in blastic transf...

Journal: :Journal of the Association for Laboratory Automation 2009

Journal: :Blood 1993
F M Uckun C W Song

The radiation sensitivity of primary clonogenic blasts from 27 children with immunologically classified CD2-CD5-CD7-CD19+slg- B-lineage acute lymphoblastic leukemia (ALL) was analyzed using leukemic progenitor cell (LPC) colony assays. Radiation survival curves of primary clonogenic blasts (ie, LPC) were constructed for each patient using computer programs for the single-hit multitarget as well...

2011
Rémi Fiancette Christelle Vincent-Fabert Estelle Guerin Franck Trimoreau Yves Denizot

Some of the most potent inflammatory mediators share a lipid origin. They regulate a wide spectrum of cellular processes including cell proliferation and apoptosis. However, the precise roles and ways (if any) in which these compounds impact the growth and apoptosis of leukemic blasts remain incompletely resolved. In spite of this, significant advances have been recently made. Here we briefly r...

Journal: :Leukemia research 2013
L H van der Helm N J G M Veeger M van Marwijk Kooy A Beeker O de Weerdt M de Groot C Alhan M Hoogendoorn L Laterveer A A van de Loosdrecht J Koedam E Vellenga G Huls

The efficacy of azacitidine has been demonstrated in acute myeloid leukemia (AML) patients with 20-30% bone marrow (BM) blasts, but limited data is available on patients with ≥30% blasts. We analyzed 55 newly diagnosed AML patients, treated with azacitidine. The overall response rate was 42%. Median overall survival (OS) was 12.3 months. We confirmed poor-risk cytogenetics, therapy-related AML,...

2003
MAX H. SCHREIER JAN ANDERSSON WALDEMAR LERNHARDT FRITZ MELCHERS

B lymphocytes can be induced to divide and form Ig-secreting clones either by Tcell help or by mitogens (1, 2). About one in three splenic lymphocytes respond to Bcell mitogens, and such activation is polyclonal: 1 clone in 1,000 produces antibodies against sheep erythrocytes (SRC), 1 1 in 500 against horse erythrocytes (HRC), and 1 in 50 against trinitrophenyl (TNP) (3-5). The presence of mito...

Journal: :Chang Gung medical journal 2006
Sheng-Tsung Chang Yen-Chuan Hsieh Li-Ping Lee Ching-Cherng Tzeng Shih-Sung Chuang

Acute myeloid leukemia (AML) with recurrent genetic abnormalities often carries a favorable prognosis. AML with inv(16)(p13q22) occurs predominantly in younger patients and usually shows granulocytic and monocytic differentiation with abnormal eosinophils. It is referred to as acute myelomonocytic leukemia with abnormal eosinophils (AMML Eo). We report a case in a 27-year-old man with leukocyto...

Journal: :The Journal of Experimental Medicine 1985
N Nara E A McCulloch

The blast cells of acute myeloblastic leukemia (AML) may be considered as a renewal population, maintained by blast stem cells capable of both self-renewal and the generation of progeny with reduced or absent proliferative potential. Blast progenitor renewal is manifested in suspension culture by an exponential increase in clonogenic cells. This growth requires that two conditions be met: first...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید